Lupus Research Alliance Announces 2026 Translational Bridge Awards to Accelerate Promising Lupus Therapies
Recipients to support the advancement of promising treatments, helping move discoveries closer to people living with lupus The...
lupus nephritis
New Findings from Lupus Research Alliance-Funded Researcher Links Common Gut Bacteria to Lupus Flares
LRA-funded researcher Gregg Silverman, MD, NYU Grossman School of Medicine, is the lead author on a new study published...
Lupus Research Alliance Hails Approval of Aurinia’s Lupkynis(TM) (voclosoporin)
First Oral Treatment for Lupus Nephritis;
Second Lupus Treatment to Receive FDA Approval in Past Month
NEW YORK, NY. January...
LRA-Funded Study Pinpoints a Key Player in Lupus Nephritis as Target for New Treatments
October 8, 2020
People with lupus often develop complications in major organs such as the kidneys, called Lupus Nephritis (LN)....
LRA Applauds GSK on Positive Phase 3 Study of Benlysta® in Lupus Nephritis
September 16, 2020
NEW YORK, NY. The Lupus Research Alliance welcomes positive BLISS-LN Phase 3 data published in this week’s...
Iguratimod as an Alternative Therapy for Resistant Lupus Nephritis
April 1, 2020
An investigational treatment, iguratimod showed positive results in an early clinical study of people with lupus nephritis...
Aurinia Moves Voclosporin Closer to FDA Approval for Lupus Nephritis
March 16, 2020
The Lupus Research Alliance is pleased to share an announcement from Aurinia Pharmaceuticals that moves its potential...
LRA Celebrates Major Research Breakthroughs in 2019
January 7, 2020
2019 was a phenomenal, breakthrough year for lupus research on both the clinical development and basic science...
New Phase 3 Study Shows Positive Results for Benlysta® in Lupus Nephritis
December 17, 2019
The Lupus Research Alliance is thrilled to share exciting news from GSK that Benlysta (belimumab) demonstrated positive...
FDA Expedites Existing Drug Gazyva for Lupus Nephritis
September 18, 2019
The LRA is pleased to share that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy...
Lupus Therapeutics Expands Collaboration with Bristol-Myers Squibb to Test Potential Treatment for Lupus
New York, NY– June 27, 2019. The Lupus Research Alliance (LRA) and clinical research affiliate, Lupus Therapeutics, broadened a collaboration...
Cyclosporine Worked Faster than Mycophenolate Mofetil or Azathioprine for Lupus Nephritis
June 12, 2019
A study presented at EULAR showed that ongoing maintenance therapy with the immunosuppressive drug cyclosporine helped lower...